Synthesis and antinociceptive activity of chimonanthines and pyrrolidinoindoline-type alkaloids

被引:66
作者
Verotta, L
Orsini, F
Sbacchi, M
Scheildler, MA
Amador, TA
Elisabetsky, E
机构
[1] Univ Milan, Dipartimento Chim Organ & Ind, I-20133 Milan, Italy
[2] GlaxoSmithKline, Neurobiol Res, I-20021 Milan, Italy
[3] Univ Fed Rio Grande do Sul, Curso Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil
[4] Univ Fed Rio Grande do Sul, Dept Farmacol, BR-90040100 Porto Alegre, RS, Brazil
关键词
D O I
10.1016/S0968-0896(02)00078-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hodgkinsine, a trimeric pyrrolidinoindoline type alkaloid, present as a major constituent of Psychotria spp. (Rubiaceae), has shown to produce dose-dependent, naloxone reversible, analgesic effect in thermal models of nociception and the capsaicin-induced pain. SAR studies have been initiated by synthesizing the three diastereomeric dimers (chimonanthines) (11-13) which were evaluated in vitro and in vivo along with the synthetic intermediates. Strong binding affinities for mu opioid receptors were found for (-)- and (+)-chimonanthine monourethanes (9 and 10), whereas (-)-, (+)- and (meso)-chimonanthine (11-13) and hodgkinsine displayed low affinity. In vivo data have shown that only (+)-chimonanthine (12) and calycosidine resemble the analgesic profile found for hodgkinsine. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2133 / 2142
页数:10
相关论文
共 33 条
[1]   Antinociceptive profile of Hodgkinsine [J].
Amador, TA ;
Verotta, L ;
Nunes, DS ;
Elisabetsky, E .
PLANTA MEDICA, 2000, 66 (08) :770-772
[2]   Involvement of NMDA receptors in the analgesic properties of psychotridine [J].
Amador, TA ;
Verotta, L ;
Nunes, DS ;
Elisabetsky, E .
PHYTOMEDICINE, 2001, 8 (03) :202-206
[3]   Effects of Psychotria colorata alkaloids in brain opioid system [J].
Amador, TA ;
Elisabetsky, E ;
deSouza, DO .
NEUROCHEMICAL RESEARCH, 1996, 21 (01) :97-102
[4]   NATURAL PLANT-CHEMICALS - SOURCES OF INDUSTRIAL AND MEDICINAL MATERIALS [J].
BALANDRIN, MF ;
KLOCKE, JA ;
WURTELE, ES ;
BOLLINGER, WH .
SCIENCE, 1985, 228 (4704) :1154-1160
[5]   FACTORS AFFECTING BINDING OF TRANS-N-[2-(METHYLAMINO)CYCLOHEXYL]BENZAMIDES AT THE PRIMARY MORPHINE RECEPTOR [J].
CHENEY, BV ;
SZMUSZKOVICZ, J ;
LAHTI, RA ;
ZICHI, DA .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (12) :1853-1864
[6]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]   Antinociceptive profile of the pseudopeptide B-2 bradykinin receptor antagonist NPC 18688 in mice [J].
Correa, CR ;
Kyle, DJ ;
Chakraverty, S ;
Calixto, JB .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (03) :552-558
[8]  
CUNNINGHAM AB, 1993, ETHICS ETHNOBIOLOGIS, P44
[9]   ALTERATIONS IN THE STEREOCHEMISTRY OF THE K-SELECTIVE OPIOID AGONIST U50,488 RESULT IN HIGH-AFFINITY OMICRON-LIGANDS [J].
DECOSTA, BR ;
BOWEN, WD ;
HELLEWELL, SB ;
GEORGE, C ;
ROTHMAN, RB ;
REID, AA ;
WALKER, JM ;
JACOBSON, AE ;
RICE, KC .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (08) :1996-2002
[10]   3-deoxyclocinnamox:: The first high-affinity, nonpeptide μ-opioid antagonist lacking a phenolic hydroxyl group [J].
Derrick, I ;
Neilan, CL ;
Andes, J ;
Husbands, SM ;
Woods, JH ;
Traynor, JR ;
Lewis, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (17) :3348-3350